✦ LIBER ✦

Current concepts on the etiology of Parkinson's disease

✍ Scribed by Donald B. Calne

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 251 KB
Volume: 4
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870040503

No coin nor oath required. For personal study only.

✦ Synopsis

In recent years, attention has repeatedly been drawn to the links between aging of the nervous system and Parkinson's disease. Associations derive from (a) the high prevalence of Parkinson's disease in the elderly; (b) the clinical similarities between normal neurological aging and the features of Parkinson's disease; (c) comparisons between normal physiological, biochemical, and morphological aging of the brain and comparable changes in Parkinson's disease; (d) the long latency between exposure to certain environmental risk factors for parkinsonism, and the appearance of clinical features; and (e) the accelerated rate of progress of Parkinson's disease of late onset versus early onset.

📜 SIMILAR VOLUMES

Etiology and pathogenesis of Parkinson's

Etiology and pathogenesis of Parkinson's disease

✍ Anthony H. Schapira; Peter Jenner 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

## Abstract The past 25 years have seen a major expansion of knowledge concerning the cause of Parkinson's disease provided by an understanding of environmental and genetic factors that underlie the loss of nigral dopaminergic neurons. Based on the actions of toxins, postmortem investigations, and

The basal ganglia in Parkinson's disease

The basal ganglia in Parkinson's disease: Current concepts and unexplained observations

✍ Jose A. Obeso; Concepcio Marin; C. Rodriguez-Oroz; Javier Blesa; B. Benitez-Temi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

Limitations of current Parkinson's disea

Limitations of current Parkinson's disease therapy

✍ Olivier Rascol; Pierre Payoux; Fabienne Ory; Joaquim J. Ferreira; Christine Bref 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Fifth annual symposium on etiology, path

Fifth annual symposium on etiology, pathogenesis, and prevention of Parkinson's disease

📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

✍ C. Warren Olanow; Yves Agid; Yoshi Mizuno; Alberto Albanese; U. Bonucelli; Phili 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract Levodopa is the most effective symptomatic agent in the treatment of Parkinson's disease (PD) and the “gold standard” against which new agents must be compared. However, there remain two areas of controversy: (1) whether levodopa is toxic, and (2) whether levodopa directly causes motor

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

✍ Manfred Gerlach; Heinz Reichmann; Peter Riederer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 1 views

## Abstract Companion letters have been published in __Movement__ Disorders: Current Controversies: Levodopa in the Treatment of Parkinson's Disease, by Sharma, Vassallo, and Ross and Reply: Levodopa in the Treatment of Parkinson's Disease, by Olanow, Agid, and Mizuno.